Newsfile Corp
23 Sept 2026, 11:40 UTC · 4h ago
Verdict
Headline takes no side. We score UNCY −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
Kaplan Fox & Kilsheimer LLP has filed a securities class action lawsuit against Unicycive Therapeutics (UNCY) regarding investors who acquired securities between December 29, 2025 and June 29, 2026.
Newpress release dated September 23, 2026
So whatLitigation overhead and potential settlement costs could impact cash runway and EPS through 2027.
More negative than 79% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The FDA issued a Complete Response Letter (CRL) on June 30, 2026, for oxylanthanum carbonate (OLC) citing the same third-party manufacturing deficiencies found in June 2025.
Priced indisclosed June 30, 2026
More negative than 71% of claims this week
The lawsuit alleges Unicycive failed to disclose that it had not inspected its third-party manufacturing vendor's facility or audited its compliance with good manufacturing practices.
Newpress release dated September 23, 2026
More negative than 71% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit following an FDA Complete Response Letter and a significant stock price drop.
More negative than 77% of ticker scores this week
The law firm is encouraging investors who suffered significant losses to contact them, implying legal issues.
More negative than 77% of ticker scores this week
The law firm is reminding investors with significant losses to seek leadership roles in a legal action.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
3h ago
−3.3%
Price agrees with the score
$4.79 vs $4.96 close before publication (Sep 22) · not market-adjusted
UNCY chart →
